Showing results (211-220 of 297) with videos related to
Sort By:
Pageof 30
Biomed Research International|June 3, 2022
Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell LymphomaZhenjie Qu, Tingting Zhang, Fenghua Gao, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 18, 2021
Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressivenessJunya Ning, Yingnan Ye, Dechao Bu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 4, 2026
Single-Cell Dissection of Tumor-Infiltrating Lymphocytes Reveals Cellular Architecture Predictive of Therapeutic Efficacy in Acral MelanomaChao Zhang, Wanyi Xiao, Hongru Shen, et al.Science Immunology|February 16, 2024
STING licensing of type I dendritic cells potentiates antitumor immunityJian Wang, Suxin Li, Maggie Wang, et al.Cancer Cell|January 3, 2008
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasisLi Yang, Jianhua Huang, Xiubao Ren, et al.Journal for Immunotherapy of Cancer|April 2, 2022
Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCLTingting Zhang, Hengqi Liu, Lei Jiao, et al.Annals of Translational Medicine|March 14, 2022
Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)Xiaobin Shang, Gang Zhao, Fei Liang, et al.Cancer Immunology, Immunotherapy : CII|November 3, 2025
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approachesAmit Sharma, Dario Sangiolo, Antonio Rosato, et al.Cancer Immunology, Immunotherapy : CII|January 27, 2024
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapyAmit Sharma, Xiubao Ren, Antonio Rosato, et al.Journal of Cancer|October 30, 2020
Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patientsYue Fei, Jingwei Yu, Yang Li, et al.Pageof 30